REPEAT: Seeing Machines loss narrows; Hansard profit falls
(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
| Price | 77.50p on 06-02-2026 at 19:40:05 |
|---|---|
| Change | 0.00p 0% |
| Buy | 80.00p |
| Sell | 75.00p |
| Last Trade: | Sell 3,995.00 at 75.20p |
| Day's Volume: | 5,947 |
| Last Close: | 77.50p |
| Open: | 77.50p |
| ISIN: | GB00BMWLM973 |
| Day's Range | 77.50p - 77.50p |
| 52wk Range: | 35.40p - 97.50p |
| Market Capitalisation: | £29.26m |
| VWAP: | 75.31517p |
| Shares in Issue: | 37.76m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Arecor Therape (AREC) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 3,995 | 75.20p | Ordinary |
10:41:31 - 06-Feb-26 |
| Sell* | 1,000 | 75.55p | Ordinary |
08:36:39 - 06-Feb-26 |
| Buy* | 1 | 80.00p | SI Trade |
08:15:09 - 06-Feb-26 |
| Sell* | 5 | 75.00p | SI Trade |
08:15:09 - 06-Feb-26 |
| Buy* | 5,000 | 78.14p | Ordinary |
14:47:43 - 05-Feb-26 |
| Buy* | 1,351 | 78.25p | Ordinary |
13:18:42 - 05-Feb-26 |
| Sell* | 2,257 | 76.25p | Ordinary |
10:48:22 - 05-Feb-26 |
| Unknown* | 1,150 | 80.00p | Ordinary |
12:06:40 - 04-Feb-26 |
| Buy* | 2 | 85.00p | SI Trade |
10:44:43 - 04-Feb-26 |
| Sell* | 4 | 75.00p | SI Trade |
10:25:12 - 04-Feb-26 |
Arecor Therape (AREC) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 6th Jan 2026 2:01 pm | RNS | Fireside Panel Discussion on Diabetes sector |
| 9th Dec 2025 7:00 am | RNS | Arecor and Sequel Med Tech to host fireside panel |
| 17th Nov 2025 11:37 am | RNS | Holding(s) in Company |
| 11th Nov 2025 9:50 am | RNS | Holding(s) in Company |
| 4th Nov 2025 7:00 am | RNS | Enhanced IP Coverage: AT278 & Oral Peptide Program |
| 29th Sep 2025 7:00 am | RNS | Directorate Changes |
| 25th Sep 2025 7:00 am | RNS | Interim results for the six months to 30 June 2025 |
| 25th Sep 2025 7:00 am | RNS | Co-Development Agreement & Monetisation Deal |
| 24th Sep 2025 9:30 am | RNS | Notice of Interim Results |
| 4th Sep 2025 7:00 am | RNS | Positive FDA Feedback on Phase 2 Study Design |